Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Non-Current Assets (2016 - 2025)

Lexaria Bioscience's Non-Current Assets history spans 11 years, with the latest figure at $687678.0 for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 28.96% year-over-year to $687678.0; the TTM value through Nov 2025 reached $687678.0, down 28.96%, while the annual FY2025 figure was $706776.0, 27.12% down from the prior year.
  • Non-Current Assets for Q4 2025 was $687678.0 at Lexaria Bioscience, down from $706776.0 in the prior quarter.
  • Across five years, Non-Current Assets topped out at $1.2 million in Q1 2021 and bottomed at $687678.0 in Q4 2025.
  • The 5-year median for Non-Current Assets is $893525.5 (2021), against an average of $897861.4.
  • The largest annual shift saw Non-Current Assets soared 52.08% in 2021 before it tumbled 31.29% in 2022.
  • A 5-year view of Non-Current Assets shows it stood at $844546.0 in 2021, then grew by 1.13% to $854110.0 in 2022, then rose by 9.25% to $933140.0 in 2023, then grew by 3.74% to $968033.0 in 2024, then fell by 28.96% to $687678.0 in 2025.
  • Per Business Quant, the three most recent readings for LEXX's Non-Current Assets are $687678.0 (Q4 2025), $706776.0 (Q3 2025), and $934588.0 (Q2 2025).